The U.S. Food and Drug Administration (FDA) has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat certain people with…
Articles by Marisa Wexler, MS
India’s Central Drugs Standard Control Organization has approved the oral therapy nor-ursodeoxycholic acid (NorUDCA) for people with metabolic dysfunction-associated steatotic…
A new artificial intelligence (AI) algorithm can help identify babies with genetic forms of cholestasis, including progressive familial intrahepatic…
The proportion of cases of hepatocellular carcinoma (HCC) attributable to fatty liver disease is set to rise in the…
A new study has uncovered a key mechanism behind the liver scarring seen in biliary atresia (BA), a rare…
The first participant has been enrolled in ECLIPSE 3, a Phase 2b clinical trial testing Vir Biotechnology’s combination treatment…
Low levels of vitamin D by-products, or metabolites, in the blood are indicative of more severe liver damage in…
Enrollment is nearly complete in a Phase 2b clinical trial that’s testing Corcept Therapeutics‘ experimental oral therapy miricorilant in…
World Hepatitis Day arrives Monday and advocates are gearing up to break down barriers that stand in the way of…
The hepatitis E virus (HEV) has long been known to infect liver cells, but researchers have now shown it…